Web1 dag geleden · Between now and 2025, investors will be watching quarterly reports with interest. Any surprises, good or bad, will likely move the stock significantly. Of the 26 analysts covering ABBV, 12 have a Buy rating, 13 give it a Hold, and one a Moderate Sell with a $164.64 average target price. However, even the analysts are sitting on the fence. Web13 apr. 2024 · Analysts’ Opinion of ABBV. Guggenheim, on the other hand, stated in their research note that they expect to see ABBV reach a price target of $172. The rating they …
How to buy AbbVie stock - (NYSE: ABBV) stock price $157.54
Web19 jul. 2024 · AbbVie has a market cap of over $285 billion. AbbVie produces close to 26 drugs, including Imbruvica, Lupron, and Humira, which accounts for roughly 37% of its revenues. While expiring patents for... Web21 uur geleden · ABBV Regular Dividend: ABBV will begin trading ex-dividend on 04/13/23 with a $1.48 dividend payable to shareholders of record as of 04/14/23. Quote. Profile. … essential web media players
Is AbbVie Stock A Buy After Earnings? (NYSE:ABBV)
Web5 feb. 2024 · Is AbbVie Stock a Buy Now? By David Jagielski – Feb 5, 2024 at 6:25AM Key Points AbbVie reported an impressive profit this past quarter, and sales were solid … Web21 sep. 2024 · For the current quarter, AbbVie is expected to post earnings of $3.59 per share, indicating a change of +7.8% from the year-ago quarter. The Zacks Consensus … WebThis video is an analysis of AbbVie Inc (ABBV) from the fiscal year 2024 financial results as well as an estimate of the future value and possible investment return based on a … firearm bill of sale free